Technology News and Research

RSS

GOSH to improve rare disease diagnosis with adoption of Congenica’s Sapientia technology

Ian was ‘a clumsy child’. He kept bumping into objects and couldn’t see well in the dark. He endured 15 years of tests and misdiagnoses during a lengthy, and sometimes traumatic, diagnostic odyssey.

26 Aug 2015

Study outlines new approach to studying public health data

A paper co-published by College of Health and Human Services faculty is demonstrating the capability of new technology that allows in-depth analysis of health outcomes amongst different groups. Published in the American Journal of Preventative Medicine, the research outlines a novel approach to studying public health data.

26 Aug 2015

Centenary Institute develops new therapeutic approach to prevent GVHD in blood cancer patients

Sydney’s Centenary Institute has developed a new therapeutic approach that could help to improve outcomes for patients undertaking treatment for blood cancer.

26 Aug 2015

Immatics US launched to develop adoptive cellular therapies for treatment of various tumors

Immatics Biotechnologies GmbH and The University of Texas MD Anderson Cancer Center announced today the launch of Immatics US, Inc., a new company aiming at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumor types.

26 Aug 2015

New research could potentially yield novel platform for cancer vaccines

New research led by Wyss Core Faculty member David Mooney, Ph.D., in collaboration with researchers at the Dana-Farber Cancer Institute could potentially yield a new platform for cancer vaccines. Leveraging a biologically inspired sponge-like gel called "cryogel" as an injectable biomaterial, the vaccine delivers patient-specific tumor cells together with immune-stimulating biomolecules to enhance the body's attack againstcancer.

26 Aug 2015

TUHS, GE Healthcare collaborate to provide high-quality radiologic imaging services

Academic medical centers across the U.S. are experiencing increasing pressure to enhance value - deliver higher quality at lower cost - as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency and quality incentives.

26 Aug 2015

Pitt and Drexel researchers team up with NIH to investigate persistence of Ebola virus in wastewater

The historic outbreak of Ebola virus disease in West Africa that began in March 2014 and has killed more than 11,000 people since, has raised new questions about the resilience of the virus and tested scientists' understanding of how to contain it. The latest discovery by a group of microbial risk-assessment and virology researchers suggests that the procedures for disposal of Ebola-contaminated liquid waste might underestimate the virus' ability to survive in wastewater.

26 Aug 2015

Researchers examine how small wireless sensors integrated into orthopedic implants can help detect SSI

A team of researchers, led by Rensselaer Polytechnic Institute Professor Eric Ledet, will investigate whether small wireless sensors incorporated into orthopedic implants could be used to detect surgical site infections. The research is supported by a $429,560 grant from the National Institutes of Health.

26 Aug 2015

Lingering cancer-related mutations linked to increased risk of relapse, poor survival in leukemia patients

For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations - detected after initial treatment with chemotherapy - are associated with an increased risk of relapse and poor survival.

26 Aug 2015

Amedica announces release of Valeo II LL interbody fusion device

Amedica Corporation, an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the release of its silicon nitride lateral lumbar interbody fusion device.

26 Aug 2015

MorphoSys, Immatics partner to develop novel antibody-based therapies against multiple proprietary cancer antigens

MorphoSys AG and Immatics Biotechnologies GmbH announced today a strategic alliance to generate novel antibody-based therapeutics against multiple proprietary cancer antigens recognized by T cells.

26 Aug 2015

Meridian Health chooses Avantas' labor management technology and services to manage workforce

Avantas, a leading provider of labor management technology, services, and strategies for the healthcare industry, today announced that Meridian Health, a leading not-for-profit health care organization in New Jersey, selected the company's labor management technology and services.

26 Aug 2015

Chrono obtains second Fast Track SBIR grant award from NCI to support development of smoking cessation therapy

Chrono Therapeutics, a pioneer in digital drug therapy, today announced it has received a second Phase 1 and Phase 2 Fast Track Small Business Innovation Research (SBIR) grant award from the National Cancer Institute.

26 Aug 2015

First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.

26 Aug 2015

Impact Advisors selected as one of Modern Healthcare's Best Places to Work in Healthcare

Impact Advisors, LLC, a leading provider of healthcare information technology services, is pleased to announce that it has been selected, for the sixth consecutive year, as one of Modern Healthcare's Best Places to Work in Healthcare. Specific rankings will be revealed during Modern Healthcare's awards gala in Nashville on October 14.

26 Aug 2015

BD Life Sciences completes acquisition of Cellular Research

BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), today announced it has completed the acquisition of Cellular Research, Inc.

From BD (Becton, Dickinson and Company) 26 Aug 2015

Sequenom, UC San Diego Moores Cancer Center collaborate to explore utility of liquid biopsy assay

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.

26 Aug 2015

Dexcom G5 Mobile Continuous Glucose Monitoring System receives FDA approval

Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System.

25 Aug 2015

The Iowa Clinic selects TCS' VirtuMedix platform to provide secure telemedicine services to family medicine patients

TeleCommunication Systems, a world leader in secure and highly reliable wireless communication technology, today announced that The Iowa Clinic, the largest physician-owned, multi-specialty group in Central Iowa, has selected TCS' VirtuMedix platform to provide secure, HIPAA-compliant telemedicine services to its family medicine patients.

25 Aug 2015

Study reveals potential health risks associated with burning of incense in indoor environments

The burning of incense might need to come with a health warning. This follows the first study evaluating the health risks associated with its indoor use. The effects of incense and cigarette smoke were also compared, and made for some surprising results. The research was led by Rong Zhou of the South China University of Technology and the China Tobacco Guangdong Industrial Company in China, and is published in Springer's journal Environmental Chemistry Letters.

25 Aug 2015

Technology News and Research

GOSH to improve rare disease diagnosis with adoption of Congenica’s Sapientia technology

Study outlines new approach to studying public health data

Centenary Institute develops new therapeutic approach to prevent GVHD in blood cancer patients

Immatics US launched to develop adoptive cellular therapies for treatment of various tumors

New research could potentially yield novel platform for cancer vaccines

TUHS, GE Healthcare collaborate to provide high-quality radiologic imaging services

Pitt and Drexel researchers team up with NIH to investigate persistence of Ebola virus in wastewater

Researchers examine how small wireless sensors integrated into orthopedic implants can help detect SSI

Lingering cancer-related mutations linked to increased risk of relapse, poor survival in leukemia patients

Amedica announces release of Valeo II LL interbody fusion device

MorphoSys, Immatics partner to develop novel antibody-based therapies against multiple proprietary cancer antigens

Meridian Health chooses Avantas' labor management technology and services to manage workforce

Chrono obtains second Fast Track SBIR grant award from NCI to support development of smoking cessation therapy

First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

Impact Advisors selected as one of Modern Healthcare's Best Places to Work in Healthcare

BD Life Sciences completes acquisition of Cellular Research

Sequenom, UC San Diego Moores Cancer Center collaborate to explore utility of liquid biopsy assay

Dexcom G5 Mobile Continuous Glucose Monitoring System receives FDA approval

The Iowa Clinic selects TCS' VirtuMedix platform to provide secure telemedicine services to family medicine patients

Study reveals potential health risks associated with burning of incense in indoor environments

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News